NCT03000608 - A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

December 13, 2017

Study Completion Date

December 14, 2017

Conditions

Plaque Psoriasis

Interventions

DRUG

SAN021 Serum

SAN021 is a serum containing 10% East Indian Sandalwood Oil. It is packaged in an amber glass bottle with a dropper top. The dose is 5 drops per 1% BSA involvement twice daily.

DRUG

SAN021 Placebo

SAN021 Placebo is a serum that does not contain East Indian Sandalwood Oil however, does contain a synthetic sandalwood fragrance. It is packaged in an amber glass bottle with a dropper top. The dose is 5 drops per 1% BSA involvement twice daily.

Trial Locations (4)

78213

Progressive Clinical Research, San Antonio

78229

Clinical Trial of Texas, San Antonio

The Dermatology Clinical Research Center of San Antonio, San Antonio

78759

DermResearch, Inc., Austin